Needham Comments On Medarex (MEDX) After Encouraging Mayo Clinic Cancer News
Tweet Send to a Friend
Analysts at Needham & Co commented on Medarex, Inc. (Nasdaq: MEDX) related to encouraging news that an ongoing Mayo Clinic ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


